Clinical Trial Update: Adjunctive D-Cycloserine in Major Depressive Disorder [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating adjunctive D-Cycloserine for major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: University of Calgary | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED